Skip Navigation

European Heart Journal 1988 9(10):1058-1066;
Copyright © 1988 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1988 The European Society of Cardiology

The German Cardiovascular Prevention Study (GCP): design and methods

GCP STUDY GROUP*

Received 28 January 1987; revised 11 March 1988; .

Address for correspondence Prof. Dr M. Zachcial. GCP-Study, Coordination Secretariate. WIAD-Wissenschaftliches Institut der Arzte Deutschlands e. V. Godesberger Allee 54, 5300 BONN 2. F.R.G

Abstract

The German Cardiovascular Prevention Study (GCP) is a multicentre community-based intervention study for the primary prevention of ischaemic heart diseases (ICD-9410-414) and cerebrovascular diseases (ICD-9430–438). It comprises a total population of 1.23 million persons in five study regions spread all over the F.R.G. Prevention measures in overlapping campaigns to modify health behaviour and life styles are aimed at the cardiovascular risk factors of cigarette smoking, elevated blood pressure, hypercholesterolaemia, overweight, and physical inactivity over a period of eight years. Age-specific cardiovascular mortality in males and females aged 25–69 years in intervention regions shall be reduced by at least 8% as compared to the mortality experience of the rest of the Federal Republic. Official mortality statistics and incidence data in parts of the study population, together with proxy measures for case fatality, will be incorporated into the evaluation strategy. Risk-factor reduction is being assessed in three health examination surveys at the start, at mid-term and at the end of the study. Further information on the effectiveness of preventive measures is obtained by process evaluation and observation of structural changes in the communities.

Key Words: Epidemiology • Ischaemic heart disease • cerebrovascular disease • lipids • cigarette smoking • hypertension


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur J Public HealthHome page
U. Laaser and J. Breckenkamp
Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol
Eur J Public Health, April 1, 2006; 16(2): 217 - 222.
[Abstract] [Full Text] [PDF]

Home page
 J. Epidemiol. Community HealthHome page
U Laaser, J Breckenkamp, A Ullrich, and B Hoffmann
Can a decline in the population means of cardiovascular risk factors reduce the number of people at risk?
J Epidemiol Community Health, March 1, 2001; 55(3): 179 - 184.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.